Key Takeaways
- Groundwork BioAg’s market expansion offers climate-smart solutions for 677 million acres.
- Rootella®, a mycorrhizal inoculant, is approved in China, Argentina, and South Africa.
- The move aligns with the global shift towards biological alternatives in agriculture.
Groundwork BioAg Expands Global Reach
Groundwork BioAg® has achieved a significant milestone with the approval of its flagship mycorrhizal inoculant, Rootella®, for commercialization in China, Argentina, and South Africa. This development adds 274 million hectares of cropland to the company’s potential customer base, responding to the growing demand for sustainable agriculture solutions.
Addressing Global Agricultural Challenges
As chemical crop protection faces increasing scrutiny, Groundwork BioAg’s expansion comes at a crucial time, providing nature-based solutions that align with global sustainability goals. The company’s presence in major agricultural markets, including the United States, Brazil, India, and Canada, positions it as a leading supplier in the biological agricultural market.
Local Partnerships and Market Readiness
Groundwork BioAg is collaborating with local partners and conducting trials in key crops like corn, soybean, wheat, and cotton. In China, positive trial results have garnered interest from local distributors, setting the stage for sales in the 2024 planting season. The company also anticipates distribution agreements in Argentina by 2024 and has already started supporting farmers in South Africa through cooperation with AGRivested.
Commitment to Sustainable Farming
Groundwork BioAg emphasizes its commitment to supporting farmers under environmental and financial pressures. The company aims to offer solutions that improve soil health and crop yield and contribute to carbon sequestration and sustainable harvests.
Photo by Karl Wiggers on Unsplash
